Table of Content

1.0 Executive Summary
1.1 Research Focus
1.2 Research Scope
1.3 Analysis Framework
1.4 Research Methodology

2.0 Technology Landscape and Trends
2.1 Technology Expertise
2.2 Methods, Strategies and Tools
2.3 Targets, Molecules and Biology
2.4 Global Technology Convergence
2.5 Translation from/to Adjacent Industries

3.0 Technology Status Review and Assessment
3.1 Emerging Opportunities for Preclinical Research Technologies
3.2 Enabling Science and Technology Developments
3.3 Medicinal Chemistry and Platform Chemistry Technologies
3.4 Organoids, Spheroids and 3D Self-Assembled Tissues
3.5 Biomimetic Sensors and Organ-on-Chip Devices
3.6 Animal Models Used in Research
3.7 Germline Gene Editing Tools and Stem Cells Reprogramming
3.8 Optical, Multimodality and Translational Imaging

4.0 Business Landscape and Intellectual Property
4.1 Preclinical Disease Models Adoption Impact
4.2 Macro to Micro Visioning and Implications
4.3 Summary of Key Industry Drivers
4.4 Summary of Key Industry Challenges
4.5 Summary of Key Market Drivers and Restraints
4.6 Mapping of Key Market Drivers and Restraints
4.7 Technology Transfer Assessment and Perceptions
4.8 Open Innovation Avenues in preclinical disease models

5.0 Technology Radar and Intelligent SOlutions
5.1 Technology Maturity Level and Description
5.2 Roadmap Tapping into Technology Synergy
5.3 Business Model Hybridization
5.4 Approaches Driving Preclinical Disease Models
5.5 Technology Synergy Reshaping Value Chain
5.6 Future Perspective of Preclinical Technology

6.0 Funding and Investment Landscape
6.1 Funding and Investment Models and Adoption
6.2 Funding Contribution Focus
6.3 Preclinical Research Funding Trends
6.4 Private Investment Distribution by Type
6.5 Public Funding Distribution by Type
6.6 Public and Private Funding by Region
6.7 Public and Private Funding to Notice

7.0 INNOVATION DYNAMICS AND Industry Evolution
7.1 Key Future Industry Trends
7.2 Levers for Growth in the Preclinical Space
7.3 Industry Dynamics in Drug Discovery
7.4 Regional Adoption Potential
7.5 Growth Opportunity Assessment
7.6 Preclinical Research Ecosystem

8.0 Companies to Watch
8.1 Companies to Watch per Technology Focus
8.2 major Innovations per Technology Segment
8.3 Medicinal Chemistry and Platform ChemistRy
8.4 Organoids, Spheroids and 3D Self-assemblies
8.5 Biomimetic Sensors and Organ-on-chip Devices
8.6 Animal Models Used in Research
8.7 Gene Editing and Stem Cells Reprogramming
8.8 Optical, Multimodal Translational Imaging

9.0 Appendix A
9.1 Key Industry Influencers
9.2 Key Industry Innovators
9.3 Key Industry Developers
9.4 Key Industry Referents
9.5 Key Industry Exemplars

10.0 Appendix B
10.1 NEW DEVELOPMENT PARTNERSHIPS IN 2019-2020
10.2 Collaboration agreements IN 2019-2020
10.3 Licensing Deals IN 2019-2020
10.4 Acquisitions and PARTNERSHIPS IN 2019-2020
10.5 Additional collaborations IN 2019-2020
Legal Disclaimer